CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. (Q46126673)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2009

edit

Language	Label	Description	Also known as
English	CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.	scientific article published in February 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

title

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

main subject

Italy

0 references

(RS)-warfarin

1 reference

based on heuristic

inferred from title

author

Paola Borgiani

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Cinzia Ciccacci

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

author name string

Vittorio Forte

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Elisabetta Sirianni

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Lucia Novelli

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Placido Bramanti

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Giuseppe Novelli

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

publication date

1 February 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

published in

Pharmacogenomics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

page(s)

261-266

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

cites work

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

CYP4F2 genetic variant alters required warfarin dose

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

retrieved

21 January 2018

Identifiers

DOI

10.2217/14622416.10.2.261

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

PubMed publication ID

19207028

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19207028

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46126673&oldid=1579847558"